Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Blood Advances|December 12, 2025
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant RecipientsMiki Nishitani, Rudi-Ann Tamara Graham, Tao Wang, et al.
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
Blood Advances|April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHDZachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2022
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA TrialTheodore W Laetsch, Shannon L Maude, Susana Rives, et al.
Transplantation and Cellular Therapy|July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTRAntonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Nature Medicine|October 3, 2018
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J Orlando, Xia Han, Catherine Tribouley, et al.
Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.
Science Translational Medicine|January 14, 2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host diseaseVictor Tkachev, James Kaminski, E Lake Potter, et al.
Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Pageof 13